Confirmed drug shortages can limit a patient’s access to needed medications and force ophthalmologists to make difficult decisions regarding patient care.
Historically, drugs in short supply have been low-profit margin generic medicines, which can be challenging to manufacture, former FDA Commissioner Scott Gottlieb, MD, said in a July 2018 statement.
The sterile, parenteral drugs have low-profit margins, so the only way to produce them is to manufacture them at a “tremendous scale,” he said.
Source: Nathan M. Radcliffe, MD
“This has resulted in fewer and fewer
Uncategorized